期刊文献+

米索前列醇不同给药途径在人工流产术前的应用效果分析 被引量:2

Analysis of the effect of different administration routes of misoprostol before induced abortion
下载PDF
导出
摘要 目的 探讨米索前列醇不同给药途径在人工流产术前的应用效果。方法 80例人工流产患者,采用随机数字表法分为对照组(28例)、观察组(27例)、研究组(25例)。三组使用药物均为米索前列醇,对照组采用阴道放置给药,观察组采用舌下含服给药,研究组采用口服给药。比较三组手术相关指标[手术时间、手术出血量、视觉模拟评分法(VAS)评分],宫口松弛程度,药物不良反应发生情况。结果 观察组患者的手术时间(1.51±0.18)min短于对照组的(2.19±0.36)min和研究组的(3.21±0.32)min,对照组患者的手术时间短于研究组,差异具有统计学意义(P<0.05)。观察组患者的手术出血量(8.41±0.60)ml少于对照组的(11.88±0.64)ml和研究组的(9.71±0.68)ml,研究组患者的手术出血量少于对照组,差异具有统计学意义(P<0.05)。观察组患者的VAS评分(2.21±0.41)分低于研究组的(3.01±0.22)分和对照组的(3.21±0.30)分,研究组患者的VAS评分低于对照组,差异具有统计学意义(P<0.05)。观察组患者的宫口松弛总有效率92.59%高于对照组的71.43%和研究组的64.00%,对照组患者的宫口松弛总有效率高于研究组,差异具有统计学意义(P<0.05)。观察组药物不良反应发生率14.81%低于对照组的39.29%与研究组的48.00%,差异具有统计学意义(P<0.05)。结论 米索前列醇不同给药途径在人工流产手术前应用效果有显著不同,其中舌下含服给药方式具有较好的疗效和安全性,可促进患者宫颈软化和膨胀,降低患者疼痛感,值得被推广应用。 Objective To discuss the application effect of different administration routes of misoprostol before induced abortion.Methods A total of 80 patients with induced abortion were divided into control group(28 cases),observation group(27 cases)and research group(25 cases)according to the random numerical table.Misoprostol was used in all three groups,with vaginal placement in the control group,sublingual administration in the observation group,and oral administration in the research group.The relative indexes[operative time,operation blood loss,visual analogue scale(VAS)score],relaxation of uterine orifice,and the incidence of adverse drug reactions among the three groups were compared.Results The operative time of(1.51±0.18)min in the observation group was shorter than that of(2.19±0.36)min in the control group and(3.21±0.32)min in the research group;the operative time in the control group was shorter than that of in the research group;the differences were statistically significant(P<0.05).The intraoperative blood loss of(8.41±0.60)ml in the observation group was less than that of(11.88±0.64)ml in the control group and(9.71±0.68)ml in the research group;the intraoperative blood loss in the research group was less than that in the control group;the differences were statistically significant(P<0.05).The VAS score of(2.21±0.41)points in the observation group was lower than that of(3.01±0.22)points in the research group and(3.21±0.30)points in the control group;the VAS score in the research group was lower than that in the control group;the differences were statistically significant(P<0.05).The total effective rate of 92.59%in the observation group was higher than that of 71.43%in the control group and 64.00%in the research group;the total effective rate of the control group was higher than that of the research group;the differences were statistically significant(P<0.05).The incidence of adverse drug reactions in the observation group was 14.81%,which was lower than that of 39.29%in the control group and 48.00%in the research group,and the difference was statistically significant(P<0.05).Conclusion Different administration routes of misoprostol before induced abortion have significantly different application effects,among which sublingual administration has better efficacy and safety,which can promote cervical softening and distension,and reduce the pain of patients,and is worthy of popularization and application.
作者 林恭芳 LIN Gong-fang(Department of Obstetrics and Gynecology,Minhou County Qingkou Town Health Center,Fuzhou 350119,China)
出处 《中国现代药物应用》 2023年第10期111-114,共4页 Chinese Journal of Modern Drug Application
关键词 米索前列醇 不同给药途径 人工流产 Misoprostol Different administration routes Induced abortion
  • 相关文献

参考文献13

二级参考文献108

  • 1黎梅.中期妊娠药物引产100例临床观察[J].求医问药(下半月),2013(1):365-365. 被引量:1
  • 2董振明,马青,曹阳,张达仁.异丙酚在人工流产手术麻醉中的应用[J].中华麻醉学杂志,1995,15(1):43-43. 被引量:82
  • 3宋亚莉,闫水蓉.米索前列醇在静脉麻醉人工流产中的应用[J].基层医学论坛,2005,9(8):715-716. 被引量:2
  • 4WHO Scientific Group. Medical methods for termination of pregnancy [J]. World Health Organ Tech Rep Ser, 1997,871: 1-110.
  • 5Herczeg J, Green K, Bygdeman M. Physiological and biochemical implications of prostaglandins from the perspective of developing safer first and second-trimester obstetrics [J]. Acta Physiol Hung, 1988,71 (2) : 159-173.
  • 6Zieman M, Fong SK, Benowitz NL, et al. Absorption kinetics of misoprostol with oral or vaginal administration [J]. Obstet Gynecol, 1997,90:88-92.
  • 7Tang OS, Schweer H, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol [J]. Hum Reprod, 2002,17(2) :332-336.
  • 8Bygdeman M. Pharmacokinetics of prostaglandins [J]. Best Pract Res Clin Obstet Gynaecol, 2003,17(5):707-716.
  • 9Alderson P, Green S, Reviewers' Handbook 4.2.1 6 [M/CD]. The Cochrane 1, 2004. Chiehester, UK: Higgins JPT, editors. Cochrane [updated December 2003], Section Library [Computer program], Issue John Wiley&Sons Ltd.
  • 10Clark M, Oxman AD, editors. Cochrane Reviewers' Handbook 4.2 [updated December 2003] [M/OL]. Review Manager (Revman) [ Computer program ]. Oxford.

共引文献194

同被引文献29

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部